Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer
恩福妥单抗联合或不联合帕博利珠单抗治疗既往未接受治疗的局部晚期或转移性尿路上皮癌患者(不适合顺铂治疗)
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.22.02887
O'Donnell, Peter H; Milowsky, Matthew I; Petrylak, Daniel P; Hoimes, Christopher J; Flaig, Thomas W; Mar, Nataliya; Moon, Helen H; Friedlander, Terence W; McKay, Rana R; Bilen, Mehmet A; Srinivas, Sandy; Burgess, Earle F; Ramamurthy, Chethan; George, Saby; Geynisman, Daniel M; Bracarda, Sergio; Borchiellini, Delphine; Geoffrois, Lionnel; Maroto Rey, Jose Pablo; Ferrario, Christiano; Carret, Anne-Sophie; Yu, Yao; Guseva, Maria; Homet Moreno, Blanca; Rosenberg, Jonathan E